Developing Key Performance Indicators for initial evaluation of Population-wide Breast Cancer Screening Programmes: Evidence from Hong Kong

Abstract

<p><u>Background:</u></p><p>Monitoring breast cancer screening programmes is an important task to ensure that the programme is effective and is often done with Key Performance Indicators (KPIs). </p><p><u>Aim:</u></p><p>This ongoing study aims to develop KPIs for the Breast Cancer Screening Pilot Programme (BCSPP), launched by the Department of Health (DH) in 2021 in Hong Kong. </p><p><u>Methods:</u></p><p>The KPIs were selected through a multi-stage process. Firstly, a scoping review was carried out to identify KPIs that were already in use in breast cancer screening programmes in other countries and territories. Then, the research team excluded KPIs, which were duplicates or not applicable for use in the BCSPP. The final selection of the KPIs will be conducted by an expert panel composed of relevant stakeholders in two stages: 1) a survey will be sent to expert panel members to rate each Key Performance Indicator on appropriateness for monitoring the BCSPP; 2) expert panel members will be invited to an in-person meeting to review survey findings and confirm a final list of KPIs for the BCSPP. </p><p><u>Interim results:</u></p><p>A total of 71 KPIs were extracted from the scoping review, of which 44 remained after removing duplicate and irrelevant KPIs. We compiled a list of stakeholders to be invited for the selection exercise of KPIs of the BCSPP, including the relevant colleges of the Hong Kong Academy of Medicine, the Hong Kong Breast Cancer Foundation, and patient support groups. </p>